Cerebral MR Perfusion Imaging Analysis of Peritumoral Tissue

Abstract

Highly malignant gliomas have an infiltrating growth making it impossible to establish the exact limits of the lesion with magnetic resonance images after contrast medium administration because the peripheral component of the lesion does not enhance. On the contrary, cerebral metastases have an expansive growth and therefore lack a peripheral component beyond the enhanced area. In some cases the MR perfusional technique can demonstrate neoplastic tissue even with little damage to the brain-blood barrier and therefore with no enhancement. Our study aimed to estimate in which cases the MR perfusion technique will characterize peripheral neoplastic tissue that fails to enhance in gliomas in order to make a differential diagnosis between gliomas and metastases. We studied 60 tumours in 53 patients with MR perfusion and conventional sequences. We evaluated the presence of hyperperfused tissue in CBV maps outside the enhanced area after contrast administration and estimated the tumoral tissue CBV. None of the metastases (24 cases) had hyperperfused peritumoural tissue which was present instead in 22/36 gliomas (infiltrating aspect in CBV maps). Moreover all the gliomas with infiltrating aspect had CBV values of the solid component of the lesion higher than gliomas with a non infiltrating aspect with a threshold value between 4.4 and 6.3. It was therefore possible to characterize 22 gliomas with infiltrating aspect in the perfusion maps and with CBV values higher than the threshold value. In addition, 17 metastases with a non infiltrating aspect were characterized with CBV values higher than the threshold. Fourteen gliomas and seven metastases both with a non infiltrating aspect in the perfusion maps and with CBV values below the threshold were not characterized. In conclusion, MR perfusion succeeded in characterizing 39 lesions out of 60.

Keywords

brain tumors magnetic resonance imaging perfusion imaging

Get full access to this article

View all access options for this article.

References

Tsuchiya

Mizutani

Hachiya

: Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors. Am J Neuroradiol 17: 1081–1086, 1996.

Mikkelsen

: Adult neoplasia: Overview. In: Gillard

Waldman

Barker

(eds) Clinical MR Neuroimaging. Cambridge University Press, Cambridge UK 2005: 279–287.

Osborn

: Diagnostic imaging: Brain. Amirsys, Altona, Manitoba, Canada 2004.

Sklar

Potter

: Metastatic brain tumors. In: Latchaw

Kucharczyk

Moseley

(eds) Imaging of the nervous system, vol II. Elsevier Mosby, Philadelphia, Pennsylvania 2005: 853–868.

Burtscher

Skagerberg

Geijer

: Proton MR Spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesion characterized by stereotactic biopsy findings. Am J Neuroradiol 21: 84–93. 2000.

Castillo

Kwock

Mukherji

: Clinical applications of proton MR spectroscopy. Am J Neuroradiol 17: 1–15, 1996.

Castillo

Kwock

: Proton MR spectroscopy of common brain tumors. Neuroimaging Clin North Am 8: 733–752, 1998.

Krabbe

Gideon

Wagn

: MR diffusion imaging of human intracranial tumours. Neuroradiology 39: 483–489, 2002.

Stadnik

Chaskis

Michotte

: Diffusion-weighted MR imaging of intracerebral masses: Comparison with conventional MR imaging and histologic findings. Am J Neuroradiol 22: 969–976, 2001.

10.

Kremer

Grand

Remy

: Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 29: 105–113, 2002.

11.

Bulakbasi

Kocaoglu

Ors

: Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 24: 225–233, 2003.

12.

Rupp

: Metastatic tumors of the central nervous system; intra-cerebral metastases as only evidence of dissemination of visceral cancer. Arch Neurol Psych 59: 635, 1948.

13.

Shin

Lee

Kwun

: Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: Preliminary results. AJR Am J Roentgenol 179: 783–789, 2002.

14.

Hakyemez

Erdogan

Ercan

: High-grade and low-grade gliomas: Differentiation by using perfusion MR imaging. Clin Radiol 60: 493–502, 2005.

15.

Law

Yang

Wang

: Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24: 1989–1998, 2003.

16.

Knopp

Cha

Johnson

Mazumdar

: Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211: 791–798, 1999.

17.

Law

Yang

Babb

: (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 25: 746–755, 2004.

18.

Lev

Ozsunar

Henson

: Glial tumor grading and outcome prediction using dynamic spinecho MR susceptibility mapping compared with conventional contrast-enhanced MR: Confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Am J Neuroradiol 25: 214–221, 2004.

19.

Kremer

Grand

Remy

: Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 29: 105–113, 2002.

20.

Provenzale

Wang

Brenner

: Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. Am J Roentgenol 178: 711–716, 2002.

21.

Law

Kazmi

Wetzel

: Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors. Am J Neuroradiol 25: 997–1005, 2004.

22.

Law

Cha

Knopp

: High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222: 715–721, 2002.

23.

Chiang

Kuo

: Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiol 46: 619–627, 2004.